ERICA STORY: Open Payments
NPI 1689002883 · WASHINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 45 payments from 18 companies in 2025. Trend: 2023 $732 · 2024 $1,077 · 2025 $728
Food & beverage: $728
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $115 |
| Novo Nordisk Inc | 7 | $112 |
| GlaxoSmithKline, LLC. | 6 | $97 |
| Viatris Specialty LLC | 4 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| PFIZER INC. | 3 | $47 |
| ABBVIE INC. | 2 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Ardelyx, Inc. | 2 | $30 |
| Lilly USA, LLC | 1 | $19 |
Products named: SHINGRIX, OTEZLA, YUPELRI, Ozempic, Kerendia, PREVNAR 20, EVENITY, XIFAXAN.
Industry payments across IN — which companies pay providers there.
